More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form 6-K KB Financial Group Inc. For: Aug 14
-
Form D/A IITM Unicorn Frontier
-
Form SCHEDULE 13G/A TXNM ENERGY INC Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form 13F-NT Boggs Michael Huff For: Jun 30
-
Form 4 BELITE BIO, INC For: Aug 12 Filed by: Lin Yu-Hsin
-
Form 4 BELITE BIO, INC For: Aug 12 Filed by: Chuang Hao-Yuan
-
Form 13F-NT Atairos Partners, L.P. For: Jun 30
-
Form SCHEDULE 13G/A Talkspace, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G SkyWater Technology, Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Rezolute, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form 6-K BW LPG Ltd For: Aug 14
-
Form SCHEDULE 13G/A Rallybio Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G Sagimet Biosciences Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G Research Alliance Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G Quince Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form N-PX EASTSPRING INVESTMENTS For: Jun 30
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K AZUL SA For: Jun 30
-
Form 13F-HR Atairos Partners GP, For: Jun 30
-
Form 4 SUMITOMO MITSUI FINANCIA For: Aug 12 Filed by: Anchi Kazuyuki
-
Form SCHEDULE 13G STANDARD BIOTOOLS INC. Filed by: Long Focus Capital Management, LLC
-
Form NT 10-Q HONG YUAN HOLDING GROUP For: Jun 30
-
Form SCHEDULE 13G Neurogene Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form 13F-NT RIVERSTONE INVESTMENT For: Jun 30
-
Form 6-K SUPER HI INTERNATIONAL For: Aug 14
-
Form 13F-HR Saudi Electronic Games For: Jun 30
-
Form 13F-NT Forbion Growth III Manag For: Jun 30
-
Form SCHEDULE 13G Aura Biosciences, Inc. Filed by: Long Focus Capital Management, LLC
-
Form SCHEDULE 13G/A Minerva Neurosciences, Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form SCHEDULE 13G JATT II Acquisition Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form 13F-HR FCPM III SERVICES B.V. For: Jun 30
-
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form 13F-NT Forbion IV Management For: Jun 30
-
Form 13F-NT Forbion Growth Managemen For: Jun 30
-
Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form 13F-HR Atairos Group, Inc. For: Jun 30
-
Form 6-K BRASKEM SA For: Jun 30
-
Form 4 17 Education & Technolog For: Aug 11 Filed by: Liu Chang
-
Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form 6-K ING GROEP NV For: Aug 14
-
Form 6-K EQUINOR ASA For: Aug 14
-
Form 13F-HR LORD, ABBETT & CO. LLC For: Jun 30
-
Form 6-K Magnum Ice Cream Co N.V. For: Aug 14
-
Form SCHEDULE 13G Cyclerion Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
-
Form 6-K STUDIO CITY INTERNATIONA For: Aug 14
